Christian Brander
Christian Brander graduated from the University of Bern in 1994 with a PhD in Immunology, having studied exogenous antigen re-presentation on HLA class and T-cell-mediated hyper-reactivity to penicillin. He spent the next 13 years at Harvard University, where he focused on cellular immunity to viral infections and the impact of host genetics on this immune response. He was awarded a Catalan Institute for Research and Advanced Studies (ICREA) senior professorship in 2008 to continue his work on host genetics and cellular immunity to viral infections, including HIV, HCV and herpesviruses such as Kaposi’s sarcoma-associated herpesvirus and Epstein-Barr virus. He is a curator of the Los Alamos HIV Immunology database and the scientific director of the Catalan HIVACAT programme for the development of effective preventive and therapeutic HIV vaccines. He is associate professor at the Chair of Infectious Diseases and Immunity of UVIC-UCC. He was rated among the most highly cited researchers of 2014 by Thompson Reuters.
Vagus Nerve Dysfunction in the Post-COVID-19 Condition: a pilot cross sectional study.
Animal models to study the neurological manifestations of the post-COVID-19 condition.
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination.
Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells.
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.